Recent studies have explored therapies such as N-acetyl-DL-leucine for ataxia symptoms, bone marrow transplant therapy to restore immune competence, and gene therapy to correct defective alleles in the ATM gene—potentially restoring ATM protein function and reducing DNA damage. The gene discussed is ATM; the disease is cerebellar ataxia.